RHENFOR Trademark

Trademark Overview


On Monday, March 11, 2019, a trademark application was filed for RHENFOR with the United States Patent and Trademark Office. The USPTO has given the RHENFOR trademark a serial number of 88334351. The federal status of this trademark filing is REGISTERED as of Tuesday, June 2, 2020. This trademark is owned by Glaxo Group Limited. The RHENFOR trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
rhenfor

General Information


Serial Number88334351
Word MarkRHENFOR
Filing DateMonday, March 11, 2019
Status700 - REGISTERED
Status DateTuesday, June 2, 2020
Registration Number6066758
Registration DateTuesday, June 2, 2020
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 17, 2020

Trademark Statements


Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, March 28, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressStevenage SG12NY
GB

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
GB

Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
GB

Trademark Events


Event DateEvent Description
Friday, October 6, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, October 6, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, October 6, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, October 6, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, October 6, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, November 8, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, November 8, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, November 8, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, June 2, 2020REGISTERED-PRINCIPAL REGISTER
Tuesday, March 17, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 17, 2020PUBLISHED FOR OPPOSITION
Wednesday, February 26, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, February 10, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, February 10, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, February 10, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, February 5, 2020ASSIGNED TO LIE
Friday, January 31, 2020TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Tuesday, October 8, 2019NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, October 8, 2019LETTER OF SUSPENSION E-MAILED
Tuesday, October 8, 2019SUSPENSION LETTER WRITTEN
Thursday, October 3, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, October 3, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, October 3, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, April 23, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, April 23, 2019NON-FINAL ACTION E-MAILED
Tuesday, April 23, 2019NON-FINAL ACTION WRITTEN
Tuesday, April 23, 2019ASSIGNED TO EXAMINER
Thursday, March 28, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, March 14, 2019NEW APPLICATION ENTERED